Lv2
140 积分 2024-06-13 加入
The Landscape of Clinical Trials for TCR-T Cell Therapy
2个月前
已完结
De novo engineered disulfide bond supersedes native interchain linkage to enhance TCR pairing and anti-tumor efficacy in T cell therapy
3个月前
已完结
Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
7个月前
已完结
Tumor organoids targeted by receptor-engineered immune cells: A promising approach for advancing cancer immunotherapy
9个月前
已完结
HBV antigen as a tumour antigen in adoptive TCR-T cell therapy for HBV-related HCC: rationale and clinical effectiveness
9个月前
已完结
皖公网安备34019202002308
